Back
AstraZeneca PLC 10K Form
Buy
61
AZN
AstraZeneca PLC
Last Price:
$92.48
Seasonality Move:
1.93%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AZN News And Ratings
See the #1 stock for the next 7 days that we like better than AZN
AZN Financial Statistics
Sales & Book Value
| Annual Sales: | $54.1B |
|---|---|
| Cash Flow: | $3.5B |
| Price / Cash Flow: | 29.25 |
| Annual Sales: | $14.80 |
| Price / Book: | 6.25 |
Profitability
| EPS (TTM): | 3.01130 |
|---|---|
| Net Income (TTM): | $9.4B |
| Gross Margin: | $40.6B |
| Return on Equity: | 22.01% |
| Return on Assets: | 8.67% |
AstraZeneca PLC Earnings Forecast
Key AstraZeneca PLC Financial Ratios
-
The Gross Profit Margin over the past 35 years for AZN is 74.98%.
-
The Selling, General & Administrative Expenses for AZN have been equal to 1.03% of Gross Profit Margin.
-
The Research & Development expenses have been 22.60% of Revenue.
-
The Interest Expense is 19.76% of Operating Income.
-
The Net Earning history of AZN is 13.02% of Total Revenues.
-
Per Share Earnings over the last 35 years have been positive in 20 years.
AstraZeneca PLC Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | AZN |
| CUSIP: | 046353 |
| Website: | astrazeneca.com |
Debt
| Debt-to-Equity Ratio: | 0.71 |
|---|---|
| Current Ratio: | 0.88 |
| Quick Ratio: | 0.66 |
Price-to-Earnings
| Trailing P/E Ratio: | 41.08 |
|---|---|
| Forward P/E Ratio: | 17.96 |
AZN Technical Analysis vs Fundamental Analysis
Buy
61
AstraZeneca PLC (AZN)
is a Buy
Is AstraZeneca PLC a Buy or a Sell?
-
AstraZeneca PLC stock is rated a BuyThe current AstraZeneca PLC [AZN] share price is $92.45. The Score for AZN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.